Article
Short communication: high prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana.
Tropical medicine & international health : TM & IH - 1 Dec 2005
Röwer Susanne, Bienzle Ulrich, Weise Alexander, Lambertz Ulrike, Forst Thomas, Otchwemah Rowland N, Pfützner Andreas, Mockenhaupt Frank P
Abstract excerpt
Recently, Ghana has changed the first-line treatment of uncomplicated malaria from chloroquine to amodiaquine (AQ) plus artesunate. AQ may cause adverse events such as agranulocytosis and hepatoxicity. The pro-drug AQ is transformed by cytochrome P450 CYP2C8 to the active metabolite N-desethylaminodiaquine. Several polymorphic variants of CYP2C8 are known, some with reduced activity. In 200 randomly selected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
